SAMHSA Urges States To Expand Pharmacists’ Authority To Increase Access To Opioid Use Disorder Medications

To expand access to medications for opioid use disorder (MOUD), the federal government is encouraging states to adopt policies that allow pharmacists to prescribe or initiate buprenorphine, a common medication used to treat opioid use disorder. The guidance anticipates opportunities for pharmacists to integrate MOUD treatment into their practices, support collaborative and team-based care, and maintain and expand MOUD-related prescribing.

The recommendation was released in a Dear Colleague Letter jointly issued by the Administration for Children and Families (ACF), the Substance Abuse and Mental Health Services Administration (SAMHSA), and the Centers for Medicare & Medicaid Services (CMS). SAMHSA . . .